Article
Engineering self-propelled tumor-infiltrating CAR T cells using synthetic velocity receptors
2023-12-14
Abstract excerpt
<h4>ABSTRACT</h4> Chimeric antigen receptor (CAR) T cells express antigen-specific synthetic receptors, which upon binding to cancer cells, elicit T cell anti-tumor responses. CAR T cell therapy has enjoyed success in the clinic for hematological cancer indications, giving rise to decade-long remissions in some cases. However, CAR T therapy for patients with solid tumors has not seen similar success. Solid tumors...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3dcf6695-24f6-5307-9216-ff7870046f60
- DOI
- 10.1101/2023.12.13.571595
